PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology
Abstract
Identifying antibodies (Abs) that neutralize infectious agents is the first step for developing therapeutics, vaccines, and diagnostic tools for these infectious agents.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2020
- Source ID
- 10.1039/c9lc01165j
Entities
People
- Arum Han
- Han Wang
- Jose A Wippold
- Joseph Tingling
- Julian L. Leibowitz
- Paul de Figueiredo
Organizations
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Texas A&M Health Science Center
- Texas A&M University
- Tsinghua University
- United States Army
- United States Department of Defense